Priority Date: 24.05.12 (US 201261651213P)

TARGETING THE GLUTAMINE TO PYRUVATE PATHWAY FOR TREATMENT OF ONCOGENIC KRAS-ASSOCIATED CANCER

  • Application ID: EP13793114
  • Status: APPLICATION WITHDRAWN

Applicants

Attorney

operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Grund Intellectual Property Group is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 24.05.2012 - Priority Date (US 201261651213P)
  • 28.11.2013 - Publication A2 (WO2013177426)
  • 08.04.2015 - Publication A2 (EP2855698)

IPC Classification